Integrated Healthcare for People Who Use Drugs: Infectious Disease, Harm Reduction, and Primary Care

Overview

A Chicago pilot program integrating primary care, infectious disease consultation, and harm reduction services for people who use drugs (PWUD) demonstrated high utilization and engagement. Over three years, 552 unique patients had 1720 clinical encounters, with a majority addressing substance use disorder (SUD) and infections such as hepatitis C and HIV.

Background

People who use drugs, especially those who inject, face elevated risks of infectious diseases including HIV, hepatitis C, and bacterial infections, alongside high rates of chronic and psychiatric conditions. Despite these risks, PWUD often underutilize primary care due to stigma, logistical barriers, and fragmented services. Syringe service programs (SSPs) are trusted community-based harm reduction sites that can serve as effective venues to colocate comprehensive healthcare services. Integrating primary care and infectious disease management within harm reduction programs may improve access and health outcomes for this vulnerable population.

Data Highlights

Key Findings

• Integration of primary care and infectious disease services within a community-based harm reduction program resulted in high healthcare utilization by PWUD.
• Majority of clinical encounters (71.3%) focused on active substance use disorder management.
• Nearly one-quarter of encounters addressed infections commonly associated with drug use, including hepatitis C and HIV.
• Patients were predominantly male with a median age of 43 and mostly covered by public insurance.
• Colocation of services helped overcome common barriers such as stigma, logistical challenges, and fragmented care.
• Trusted outreach workers with lived experience facilitated referrals and engagement in care.

Clinical Implications

Colocating infectious disease and primary care services within harm reduction programs can effectively engage PWUD in comprehensive healthcare, addressing both substance use and infectious complications. This model reduces barriers related to stigma and access, suggesting that healthcare providers should consider integrated, community-based approaches to improve outcomes in this population.

Conclusion

The Chicago pilot program demonstrates that embedding comprehensive healthcare services within harm reduction settings is a feasible and effective strategy to meet the complex needs of PWUD. Such integrated models hold promise for improving health equity and reducing morbidity in this vulnerable group.

References

1. Article Source 2024 -- Integrated Healthcare Approaches for Individuals Who Use Drugs